Gynecological Cancers: Progress and Challenges
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 29
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gynecological cancers, including ovarian, cervical, and endometrial cancers, remain a major challenge in women’s health worldwide due to their complex pathogenesis, late-stage diagnosis, and limited therapeutic options. Recent advances in molecular biology, immunology, and precision medicine have uncovered novel therapeutic targets and pathways, offering new opportunities for improved treatment strategies. This Special Issue aims to bring together original research and comprehensive reviews that explore innovative therapeutic targets, novel drug candidates, and translational strategies for gynecological cancers. We particularly encourage submissions addressing molecular mechanisms, targeted therapy, immunotherapy, resistance pathways, biomarkers, and the integration of natural products or bioactive compounds in cancer therapy. By highlighting both progress and challenges, this Special Issue seeks to provide a platform for advancing scientific understanding and fostering clinical translation in the fight against gynecological cancers.
Dr. Yi-Fen Chiang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecological cancer
- therapeutic targets
- precision medicine
- immunotherapy
- drug resistance
- biomarkers
- molecular mechanisms
- natural compound
- translational research
- adjuvant therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
